Results 41 to 50 of about 31,431 (154)

Avoiding early diagnosis

Journal of General and Family Medicine, EarlyView.
Takao Wakabayashi, Goh Keng Wee, Mikinosuke Ishibashi, Yoshiki Akiyama, Naoki Kanda, Tomoyuki Watanabe   +5 more
wiley   +1 more source

Bilateral nontraumatic subcapsular renal haematoma (Wunderlich syndrome) in a Thoroughbred broodmare

Equine Veterinary Education, EarlyView.
Summary This case report describes a Thoroughbred broodmare referred for colic and pyrexia. The mare had a history of repeated urinary tract infections, placentitis, abortion and endotoxaemia. A diagnosis of bilateral subcapsular renal haematoma was made by ultrasonography and standing laparoscopy and confirmed on post‐mortem.
M. Hannan, D. Verwilghen, F. Gibbons, C. Burden, R. Liechti, O. Forde, N. Meyer, V. Roati, B. Remaj, G. van Galen   +9 more
wiley   +1 more source

Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

International Journal of Urology, Volume 32, Issue 3, Page 270-276, March 2025.
Abstract Background While the occurrence of immune‐related adverse events has been recognized as a prognostic marker in patients receiving immune checkpoint inhibitors, the prognostic significance of treatment‐related adverse events (trAEs) in patients undergoing antibody–drug conjugates such as enfortumab vedotin (EV) is controversial.
Satoru Taguchi, Taketo Kawai, Yoshiki Ambe, Kenjiro Kishitani, Michio Noda, Tomoyuki Kaneko, Jimpei Miyakawa, Yu Nakamura, Hayato Hoshina, Daisuke Obinata, Kenya Yamaguchi, Shigenori Kakutani, Yoshitsune Furuya, Yujiro Sato, Yume Adachi, Kazuma Sugimoto, Keigo Sato, Mariko Tabata, Takehiro Tanaka, Katsuhiko Nara, Yukari Uemura, Jun Kamei, Yoshiyuki Akiyama, Yusuke Sato, Yuta Yamada, Aya Niimi, Daisuke Yamada, Tappei Takada, Sayuri Takahashi, Yukio Yamada, Hideyo Miyazaki, Yutaka Enomoto, Hiroaki Nishimatsu, Tetsuya Fujimura, Hiroshi Fukuhara, Tohru Nakagawa, Satoru Takahashi, Haruki Kume   +37 more
wiley   +1 more source

Editorial: Severe fever with thrombocytopenia syndrome

Frontiers in Microbiology, 2023
Li-Fen Hu, Li-Fen Hu, Li-Fen Hu, Yun-Jia Ning, Yun-Jia Ning, Jia-Bin Li, Jia-Bin Li, Jia-Bin Li   +7 more
openaire   +3 more sources

Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome

International Journal of General Medicine, 2020
This study was to investigate the clinical characteristics and laboratory parameters of severe fever with thrombocytopenia syndrome (SFTS).A detailed retrospective analysis of clinical records for SFTS patients was conducted. Fifty-one cases confirmed SFTS virus infected were enrolled.
Fei Wang, Yunjuan Wu, Jie Jiao, Jun Wang, Zheng Ge   +4 more
openaire   +5 more sources

A new era in myeloma: the advent of chimeric antigen receptor‐T (CAR‐T) cells and bispecific antibodies

Internal Medicine Journal, Volume 55, Issue 5, Page 714-721, May 2025.
Abstract T‐cell re‐directional therapies, including chimeric antigen receptor (CAR)‐T cell and bispecific antibodies (BsA), have transformed the treatment landscape to benefit patients with multiple myeloma. A number of these novel therapies has been approved internationally, with CAR‐T therapy recently approved in Australia.
P. Joy Ho, Eric W. Li
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

Plant viruses convergently target NPR1 with various strategies to suppress salicylic acid‐mediated antiviral immunity

Journal of Integrative Plant Biology, Volume 67, Issue 5, Page 1395-1412, May 2025.
Viral infection triggers monomerization and nuclear translocation of the salicylic acid receptor NONEXPRESSOR OF PATHOGENESIS‐RELATED GENES1 (NPR1) to activate pathogenesis‐related gene expression. Nevertheless, viruses have developed one or more proteins to target NPR1 and impair its functionality through mechanisms such as inducing its degradation ...
Xue Jiang, Yingshuai Yang, Yong Li, Yongzhi Wang, Bernardo Rodamilans, Weiqin Ji, Xiaoxia Wu, Juan Antonio García, Xiaoyun Wu, Xiaofei Cheng   +9 more
wiley   +1 more source

‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis

BJU International, EarlyView.
Lu Dongming, Ye Shuchao, Xie Xueping, Zheng Luoping, Liao Shangfan, Wu Yongyang   +5 more
wiley   +1 more source

Prognostic factors and long‐term outcome in dogs diagnosed with primary and secondary immune thrombocytopenia in Ireland

Journal of Small Animal Practice, Volume 66, Issue 5, Page 305-313, May 2025.
Objectives The objectives of this study were to describe the outcome and prognostic factors in dogs diagnosed with primary and secondary immune thrombocytopenia (ITP). Materials and Methods Medical records of dogs diagnosed with primary and secondary ITP in a referral hospital in Ireland were retrospectively evaluated.
E. López‐Bailén, A. Duclos, D. Mullany, K. Le Boedec, B. Cuq   +4 more
wiley   +1 more source